Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
05/2009
05/05/2009US7528167 Inhibitors of papilloma virus
05/05/2009CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
04/2009
04/30/2009WO2009055357A1 Diazepane compounds which modulate the cb2 receptor
04/30/2009WO2009055331A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
04/30/2009WO2009054814A1 Functionalized poly (3,4-alkylenebridgedthiophene) (pabt)
04/30/2009WO2009053715A1 Thienopyrimidiene derivatives as pi3k inhibitors
04/30/2009WO2009053268A1 Novel phenyl-substituted piperazino-dihydrothienopyrimidines
04/30/2009WO2009028900A3 Oral administration drug comprising clopidogrel besylate
04/30/2009US20090111835 Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group
04/30/2009US20090111195 Chemical reagents and methods for detection and quantification of proteins in complex mixtures
04/30/2009CA2703203A1 Bicyclic heterocycle derivatives and methods of use thereof
04/30/2009CA2702772A1 Diazepane compounds which modulate the cb2 receptor
04/30/2009CA2702447A1 New phenyl-substituted piperazino-dihydrothienopyrimidines
04/30/2009CA2701292A1 Process for making thienopyrimidine compounds
04/30/2009CA2701276A1 Thienopyrimidiene derivatives as pi3k inhibitors
04/29/2009EP2053393A1 Pladienolide target molecule, compound capable of binding to the target molecule, and screening method for the compound
04/29/2009EP2051983A1 Ntetrahydropyridothiophene derivatives for the treatment of cancer
04/29/2009EP2051982A1 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors
04/29/2009EP2051711A1 Thieno[3,2-c]pyridine-7-carboxylic acid derivatives
04/29/2009EP1438288B1 Substituted thioacetamides
04/29/2009CN101421268A Pyrazoloquinolones as potent PARP inhibitors
04/29/2009CN101421265A Thiazole compounds as protein kinase b (pkb) inhibitors
04/28/2009US7524922 Poly(benzodithiophenes)
04/28/2009US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
04/28/2009US7524861 Process for the preparation of a hydrate of an anthranilic acid derivative
04/28/2009US7524853 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes
04/28/2009US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics
04/23/2009WO2009052138A1 Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein
04/23/2009WO2009051244A1 Heterocyclic compound
04/23/2009WO2009051112A1 Amide compounds and use of the same
04/23/2009WO2009050248A1 Substituted piperidino-dihydrothienopyrimidines
04/23/2009WO2009050242A2 Heterocycle-substituted piperazino-dihydrothienopyrimidines
04/23/2009WO2009050236A1 Novel piperazino-dihydrothienopyrimidine derivatives
04/23/2009WO2009049743A1 5-cyano-thienopyridines for the treatment of tumors
04/23/2009WO2009017719A3 Modulators of ccr9 receptor and methods of use thereof
04/23/2009US20090105289 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
04/23/2009US20090105244 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
04/23/2009US20090105233 Serine-threonine protein kinase and parp modulators
04/23/2009US20090105227 Thienopyrroles As Antiviral Agents
04/23/2009DE102007049451A1 5-Cyano-thienopyridine 5-cyano-thienopyridine
04/23/2009CA2705414A1 Substituted piperidino-dihydrothienopyrimidines
04/23/2009CA2702551A1 5-cyanothienopyridines
04/23/2009CA2702524A1 Heterocycle-substituted piperazino-dihydrothienopyrimidines
04/23/2009CA2702518A1 New piperazino-dihydrothienopyrimidine derivatives
04/23/2009CA2702500A1 Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein
04/22/2009EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
04/22/2009EP2049536A2 Polycyclic viral inhibitors
04/22/2009EP2049472A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators
04/22/2009EP1539761B1 6,7-dihydro-5h-pyrazolo¬1,2-a pyrazol-1-ones which control inflammatory cytokines
04/22/2009CN101415715A Fused ring compound and method for producing same, polymer, organic thin film containing those, and organic thin film device and organic thin film transistor comprising such organic thin film
04/22/2009CN101415708A HIV inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
04/22/2009CN101412726A Novel heterocyclic compounds
04/22/2009CN101412721A 6,13-substituted pentacene and derivatives thereof, as well as preparation
04/22/2009CN101412651A Pentacenes and derivatives thereof, as well as thereof
04/22/2009CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents
04/21/2009US7521460 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor
04/21/2009US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
04/21/2009CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents
04/21/2009CA2228038C 2(1h)-quinolone derivatives, their preparation and their use in therapy
04/16/2009US20090099363 Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
04/16/2009US20090099356 Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction
04/16/2009US20090098133 3-Cyano-2-[3-(2-ethoxy-phenyl)-propanoylamino]-4,7-dihydro-5H-thieno[2,3-c]pyridine-6-carboxylic acid tert-butyl ester; cell-cycle specific inducers of apoptosis in cancer cells
04/16/2009US20090098086 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors
04/15/2009EP2046799A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
04/14/2009US7518000 For therapy of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK); 2-(1H-thieno[3,2-c]pyrazol-3-yl)-1H-benzimidazole
04/14/2009US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation
04/14/2009US7517986 Such as N-(6-ethoxycarbonyl-3-cyano-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)nicotinamide; cell-cycle specific inducers of apoptosis specific to cells with aberrant cell growth
04/14/2009US7517904 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
04/14/2009US7517879 Pyrrolidine derivatives as factor Xa inhibitors
04/14/2009US7517532 Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors
04/14/2009US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
04/09/2009WO2008058285A3 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors
04/09/2009US20090093635 PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE
04/09/2009US20090093629 Process for preparation of triazol-benzodiazepine derivatives
04/09/2009US20090093456 Novel mch receptor antagonists
04/08/2009EP2045252A2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
04/08/2009EP2044083A1 Antiviral agents
04/08/2009EP2044082A1 Substituted benzodithiophenes and benzodiselenophenes
04/08/2009EP2043612A1 A stable olanzapine formulation with antioxidants
04/08/2009EP1448566B3 Chemokine receptor antagonists and methods of use thereof
04/08/2009EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
04/08/2009CN101402643A Industrial production method for prasugrel
04/08/2009CN101402642A Novel environment friendly preparation method for prasugrel
04/08/2009CN101402641A Oxime derivatives containing thienopyridine, preparation method and application thereof
04/08/2009CN101402556A New compound 1-cyclopropyl-2-(2-fluorine phenyl)-2-hydroxyl ethanone, preparation method and application thereof
04/07/2009CA2400554C Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
04/02/2009WO2009041591A1 Fused pyridine derivative
04/02/2009WO2008124000A3 Thiazole derivatives as androgen receptor modulator compounds
04/02/2009WO2008106019A3 Fused thiophenes, methods for making fused thiophenes, and uses thereof
04/02/2009WO2007032818A3 Compounds and compositions to control abnormal cell growth
04/01/2009EP2041143A1 Quinazoline derivatives, their preparation, their use as tyrosine kinase inhibitors and medicaments comprising them
04/01/2009EP2041124A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators
04/01/2009EP2001889A4 Method for preparing clopidogrel 1,5-naphthalenedisulfonate or hydrate thereof
04/01/2009EP1994013A4 PROCESS FOR PRODUCING PURE AND STABLE FORM OF 2-METHYL-4-(4- METHYL- 1 -PIPERAZINYL)-10H-THIENO[2,3-b] [1,5]BENZODIAZEPINE
04/01/2009EP1899354B1 Synthesis of deoxybiotinyl hexamethylenediamine-dota
04/01/2009EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors
04/01/2009EP1312671B1 Magnetic particles having lower limit critical solution temperature
04/01/2009CN101400683A Process for the preparation of olanzapine
04/01/2009CN101400674A Antibiotic compounds
04/01/2009CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 214